6-Iodo-tetrahydro-pyran-2,3,4,5-tetraol

ID: ALA1159547

Chembl Id: CHEMBL1159547

PubChem CID: 46905197

Max Phase: Preclinical

Molecular Formula: C6H11IO5

Molecular Weight: 290.05

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  OC1O[C@@H](CI)[C@@H](O)[C@@H](O)[C@@H]1O

Standard InChI:  InChI=1S/C6H11IO5/c7-1-2-3(8)4(9)5(10)6(11)12-2/h2-6,8-11H,1H2/t2-,3+,4+,5-,6?/m0/s1

Standard InChI Key:  HOPLQCPVSBDZRN-DHVFOXMCSA-N

Alternative Forms

Associated Targets(Human)

SW613 (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

L1210 (27553 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
P388 (20296 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 290.05Molecular Weight (Monoisotopic): 289.9651AlogP: -1.78#Rotatable Bonds: 1
Polar Surface Area: 90.15Molecular Species: NEUTRALHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 11.30CX Basic pKa: CX LogP: -1.12CX LogD: -1.12
Aromatic Rings: Heavy Atoms: 12QED Weighted: 0.34Np Likeness Score: 2.13

References

1. Sufrin JR, Bernacki RJ, Morin MJ, Korytnyk W..  (1980)  Halogenated L-fucose and D-galactose analogues: synthesis and metabolic effects.,  23  (2): [PMID:7359528] [10.1021/jm00176a008]
2. May JA, Sartorelli AC..  (1979)  Synthesis and biological activity of potential antimetabolites of L-fucose.,  22  (8): [PMID:573800] [10.1021/jm00194a017]

Source